Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T2000 in Essential Tremor
NCT00321087Phase 2Terminated
- Start
- Aug 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of T-2000 in essential tremor (ET). Started Aug 2006; status: terminated.
02
Drugs
T-2000
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT00321087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321087.